Stocks To Buy Right - Now 2017

Small-to-mid cap biotechs saw astronomical gains; Madrigal Pharmaceuticals (MDGL) rose 516% , while Sangamo Therapeutics (SGMO) gained 438% . The Losers:

Gained 19.4% for the year, achieving positive returns in every single month—a feat never before recorded in history.

+95% (Consumer Discretionary) – Benefited from a recovery in the Macau gambling market. stocks to buy right now 2017

+88% (Technology) – Profited from a massive surge in demand and pricing for memory chips (DRAM/NAND).

The standout sector, gaining approximately 36% . +88% (Technology) – Profited from a massive surge

The only two S&P sectors to finish the year in the red.

+81% (Technology) – Continued its dominance by expanding from gaming into AI and data centers. +81% (Technology) – Continued its dominance by expanding

Rose nearly 30% , driven by the explosive performance of technology stocks. Dow Jones Industrial Average: Gained over 25% .